Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,526 signal articles · 28 in last 24h · 122,310 total before filter · latest 1h ago
28last 24h
1247last 7d
210● bullish (7d)
149● bearish (7d)
205publishers
AllMacro209Earnings429M&A97Regulatory24Product9Analyst10
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Adeia Lawsuit Against DISH Puts Patent Model And Valuation In Focus
Simply Wall St.139d agobearish
Adeia Lawsuit Against DISH Puts Patent Model And Valuation In Focus

Adeia, ticker NasdaqGS:ADEA, has filed a patent infringement lawsuit against DISH Network over five core media and pay TV technologies. The company alleges unauthorized use of foundational patents that sit at the center of its licensing and media technology business. Adeia has reiterated its financial guidance while pursuing this action, highlighting the role of patent enforcement in its business model. Adeia enters this dispute with recent share price momentum and a current price of...

Investing.com140d agobearish
How could the DOJ shakeup affect the Powell investigation?

Investing.com -- A sudden leadership change at the Department of Justice (DOJ) could provide a strategic opening for Senate Republicans to derail the ongoing investigation into Federal Reserve Chair Jerome Powell, according to a public policy analysis from Barclays.

SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026
Insider Monkey148d agobearish
SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is one of the popular penny stocks on Robinhood to buy. On March 17, SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) announced that it will present preclinical data on SLS009 at the American Association for Cancer Research annual meeting on April 21, 2026. SLS009, alternatively known as tambiciclib, is a […]

Fidelity’s ETF For Russell 1000 Large-Cap Growth
24/7 Wall St.152d agobearish
Fidelity’s ETF For Russell 1000 Large-Cap Growth

Fidelity Enhanced Large Cap Growth ETF (NYSEARCA:FELG) has slipped about 8% since the start of 2026, tracking closely with its benchmark as large-cap growth stocks broadly retreat. The fund gives investors exposure to the Russell 1000 Growth universe with a quantitative edge: Fidelity runs multifactor models to tilt toward companies with strong fundamentals and reasonable ... Fidelity’s ETF For Russell 1000 Large-Cap Growth

Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run
Simply Wall St.153d agobearish
Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run

Assessing recent moves in SELLAS Life Sciences Group (SLS) SELLAS Life Sciences Group (SLS) has drawn attention after a recent run in its share price, with returns over the past 3 months and year that stand out against its mixed multi year track record. Over the past month the stock shows a gain, alongside a much stronger move in the past 3 months and a very large 1 year total return, while 5 year performance remains negative. That mix often prompts investors to revisit the story behind the...

SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths
24/7 Wall St.155d agobearish
SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths

A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS Life Sciences Group (NASDAQ:SLS) is at a genuinely unusual inflection point. Its shares have climbed 346% over the past year, yet the stock pulled back 13.4% in the past week to $5.04, with Q4 earnings due March 19. The reason Reddit is buzzing: ... SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths

A Look At Infineon Technologies (XTRA:IFX) Valuation After UBS Downgrade On AI And China Auto Concerns
Simply Wall St.161d agobearish
A Look At Infineon Technologies (XTRA:IFX) Valuation After UBS Downgrade On AI And China Auto Concerns

UBS downgrade puts Infineon’s AI and China auto exposure in focus UBS cut its rating on Infineon Technologies (XTRA:IFX) to Neutral, highlighting what it sees as limited upside in the company’s AI-related business and forecasting 7% annual declines in China auto revenue in 2026 and 2027. See our latest analysis for Infineon Technologies. Infineon’s shares have been choppy recently, with a 1 month share price return of an 8.45% decline, even as the 90 day share price return of 9.77% and 1 year...

DME Capital Sells Seadrill Shares
Motley Fool162d agobearish
DME Capital Sells Seadrill Shares

Seadrill delivers offshore drilling services worldwide, serving oil majors with a fleet of advanced rigs and a global client base.

SELLAS Life Sciences (SLS) Is Up 18.0% After Positive AML Trial Updates – What’s Changed
Simply Wall St.166d agobearish
SELLAS Life Sciences (SLS) Is Up 18.0% After Positive AML Trial Updates – What’s Changed

In late 2025, SELLAS Life Sciences Group reported encouraging Phase 2 data for SLS009 in combination with azacitidine and venetoclax in relapsed or refractory acute myeloid leukemia and confirmed that its Phase 3 REGAL trial of Galinpepimut-S would continue unchanged after an Independent Data Monitoring Committee review. Taken together, these developments highlight both near-term clinical momentum around SLS009 and growing validation of Galinpepimut-S as a potential maintenance therapy in...